NCT01370694 2019-03-15Study of MK-8808 for Participants With Follicular Lymphoma (MK-8808-001)Merck Sharp & Dohme LLCPhase 1 Terminated7 enrolled 7 charts
NCT00562965 2018-01-09Study Comparing Inotuzumab Ozogamicin In Combination With Rituximab Versus Defined Investigator's Choice In Follicular Non-Hodgkin's Lymphoma (NHL)PfizerPhase 3 Terminated29 enrolled 14 charts